Trial Outcomes & Findings for Transcranial Direct Current Stimulation for Chronic Low Back Pain (NCT NCT02768129)

NCT ID: NCT02768129

Last Updated: 2019-08-20

Results Overview

Subscale C of the West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) is a validated measure of chronic pain's effects on functioning. Ranging from 0-108, higher scores indicate more activity (better outcome).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

8 weeks total

Results posted on

2019-08-20

Participant Flow

Of the 30 participants that were consented, 9 participants were ineligible, withdrew, or were lost to contact before commencing tDCS.

Participant milestones

Participant milestones
Measure
Sham tDCS
10 sessions sham transcranial direct current stimulation (tDCS) sham transcranial direct current stimulation: sham
Active tDCS
10 sessions active transcranial direct current stimulation (tDCS) transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins
Overall Study
STARTED
11
10
Overall Study
COMPLETED
11
10
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Transcranial Direct Current Stimulation for Chronic Low Back Pain

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active tDCS
n=10 Participants
10 sessions sham transcranial direct current stimulation (tDCS) sham transcranial direct current stimulation: active : 2 mA, 20 mins
Sham tDCS
n=11 Participants
10 sessions sham transcranial direct current stimulation (tDCS) sham transcranial direct current stimulation: sham
Total
n=21 Participants
Total of all reporting groups
Age, Continuous
65.7 years
STANDARD_DEVIATION 8.8 • n=93 Participants
60.7 years
STANDARD_DEVIATION 11.8 • n=4 Participants
63.1 years
STANDARD_DEVIATION 10.5 • n=27 Participants
Sex: Female, Male
Female
1 Participants
n=93 Participants
2 Participants
n=4 Participants
3 Participants
n=27 Participants
Sex: Female, Male
Male
9 Participants
n=93 Participants
9 Participants
n=4 Participants
18 Participants
n=27 Participants
Race/Ethnicity, Customized
White
7 Participants
n=93 Participants
7 Participants
n=4 Participants
14 Participants
n=27 Participants
Race/Ethnicity, Customized
Black or African American
0 Participants
n=93 Participants
1 Participants
n=4 Participants
1 Participants
n=27 Participants
Race/Ethnicity, Customized
Hispanic or Latino
1 Participants
n=93 Participants
0 Participants
n=4 Participants
1 Participants
n=27 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race/Ethnicity, Customized
Asian
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race/Ethnicity, Customized
Native Hawaiian or other Pacific Islander
0 Participants
n=93 Participants
0 Participants
n=4 Participants
0 Participants
n=27 Participants
Race/Ethnicity, Customized
Other
2 Participants
n=93 Participants
3 Participants
n=4 Participants
5 Participants
n=27 Participants
Years of Education
14.0 years
STANDARD_DEVIATION 2.6 • n=93 Participants
14.7 years
STANDARD_DEVIATION 2.6 • n=4 Participants
14.4 years
STANDARD_DEVIATION 2.7 • n=27 Participants

PRIMARY outcome

Timeframe: 8 weeks total

Subscale C of the West Haven-Yale Multidimensional Pain Inventory (WHY-MPI) is a validated measure of chronic pain's effects on functioning. Ranging from 0-108, higher scores indicate more activity (better outcome).

Outcome measures

Outcome measures
Measure
Sham tDCS
n=11 Participants
10 sessions sham transcranial direct current stimulation (tDCS) sham transcranial direct current stimulation: sham
Active tDCS
n=10 Participants
10 sessions active transcranial direct current stimulation (tDCS) transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins
West Haven-Yale Multidimensional Pain Inventory (General Activity Subscale) Rating
35.3 score on a scale
Standard Deviation 17.7
48.4 score on a scale
Standard Deviation 21.2

PRIMARY outcome

Timeframe: 8 weeks total

The Pain Anxiety Symptom Scale (PASS-20) is a validated measure of pain-related avoidance and fear. Total score ranges 0-100. Higher scores indicate greater pain anxiety.

Outcome measures

Outcome measures
Measure
Sham tDCS
n=11 Participants
10 sessions sham transcranial direct current stimulation (tDCS) sham transcranial direct current stimulation: sham
Active tDCS
n=10 Participants
10 sessions active transcranial direct current stimulation (tDCS) transcranial direct current stimulation: active stimulation: 2 milliamp (mA), 20 mins
Pain Anxiety Symptom Scale Rating
26.4 score on a scale
Standard Deviation 22.0
26.3 score on a scale
Standard Deviation 23.6

Adverse Events

Sham tDCS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Active tDCS

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Benjamin Greenberg

Butler Hospital

Phone: (401) 455-6200

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place